Prograf and Livalo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prograf (tacrolimus) and Livalo (pitavastatin calcium). Common drug interactions include pyrexia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Prograf and Livalo. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

What is Livalo?

Livalo has active ingredients of pitavastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 8,802 Livalo users. Check the latest studies of Livalo.



On Jul, 17, 2026

39 people who take Prograf and Livalo together, and have interactions are studied.

Prograf and Livalo drug interactions.

What are the common drug interactions of Prograf and Livalo, by gender? *:

female:

  1. Pyrexia (fever)
  2. Cough
  3. Decreased appetite
  4. Dyspnoea (difficult or laboured respiration)
  5. Lower respiratory tract infection
  6. Sinusitis (inflammation of sinus)
  7. Rash
  8. Cellulitis (infection under the skin)
  9. Cytomegalovirus infection
  10. Febrile neutropenia (fever with reduced white blood cells)

male:

  1. Pyrexia (fever)
  2. Pain
  3. Immunosuppressant drug level increased
  4. Influenza
  5. Oral herpes (viral infection of mouth)
  6. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  7. Pruritus (severe itching of the skin)
  8. Rash
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Swelling

What are the common drug interactions of Prograf and Livalo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)

20-29:

  1. Aphthous ulcer (mouth ulcer)
  2. Cough
  3. Diarrhoea infectious (bacteria, viruses, and other germs can cause diarrhoea)
  4. Eating disorder
  5. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  6. Fungal skin infection
  7. Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)
  8. Head injury
  9. Immunosuppressant drug level increased
  10. Influenza

30-39:

  1. Eosinophilic myocarditis (acute and fulminate congestive heart failure)

40-49:

  1. Anal abscess
  2. Pneumonia
  3. Anaemia (lack of blood)
  4. Anal fistula
  5. Blood potassium increased
  6. Carbuncle (a carbuncle is an abscess larger than a boil)
  7. Cardiac failure
  8. Cardiac pacemaker replacement
  9. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  10. Febrile neutropenia (fever with reduced white blood cells)

50-59:

  1. Arthralgia (joint pain)
  2. Cellulitis (infection under the skin)
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Hypertension (high blood pressure)
  5. Inflammation
  6. Intestinal perforation (complete penetration of the wall of the intestine)
  7. Liver disorder (liver diseases)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Pyrexia (fever)
  10. Skin ulcer

60+:

  1. Pyrexia (fever)
  2. Cough
  3. Cytomegalovirus infection
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Herpes zoster
  6. Septic shock (shock due to blood infection)
  7. Anaemia (lack of blood)
  8. Aortic embolus (obstruction of aortic artery)
  9. Cerebral infarction (less blood supply to brain resulting tissue damage)
  10. Death

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 28.21%
  2. Osteoporosis (bones weak and more likely to break): 5 people, 12.82%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 12.82%
  4. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 10.26%
  5. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 10.26%
  6. High Blood Pressure: 4 people, 10.26%
  7. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 4 people, 10.26%
  8. Dyslipidaemia (abnormal amount of lipids): 4 people, 10.26%
  9. Diabetes: 3 people, 7.69%
  10. Type 2 Diabetes: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Prograf and Livalo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prograf and Livalo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Livalo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Livalo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus and pitavastatin calcium (the active ingredients of Prograf and Livalo, respectively), and Prograf and Livalo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: